Creyon Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 46

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 7

Creyon General Information

Description

Developer of drugs designed to engineer RNA-based medicines and their components. The company creates proprietary, purpose-built datasets that inform powerful machine learning models, identifying the design rules and engineering principles for safe and effective OBMs, enabling the healthcare sector to save costs for new medicines.

Contact Information

Website
www.creyon.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 8 Davis Drive
  • Suite 220
  • Durham, NC 27709
  • United States
+1 (760)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 8 Davis Drive
  • Suite 220
  • Durham, NC 27709
  • United States
+1 (760)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Creyon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 16-Apr-2025 Completed Generating Revenue
2. Early Stage VC (Series A) 08-Mar-2022 Completed Generating Revenue
1. Seed Round 01-Mar-2020 $5.5M $5.5M Completed Startup
To view Creyon’s complete valuation and funding history, request access »

Creyon Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed-2
Seed-1 10,998,308 $0.000010 $0.47 $0.47 1x $0.47 20.25%
To view Creyon’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Creyon Patents

Creyon Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026080452-A1 Fluorosulfonyl phosphoramidate (fsp) backbone modification and uses thereof Pending 07-Oct-2024
US-20260226477-A1 Transferrin receptor (tfr) aptamers and use thereof Pending 03-Jul-2024
WO-2026011165-A1 Transferrin receptor (tfr) aptamers and use thereof Pending 03-Jul-2024
US-20250384958-A1 Dose-response model for accurate detection and quantification of transcriptome-wide gene knockdown for oligonucleotide-based medicines Pending 24-May-2024
WO-2024226802-A2 Compositions and methods for allele specific modulation of tnpo2 expression Inactive 26-Apr-2023 C12N15/113
To view Creyon’s complete patent history, request access »

Creyon Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Creyon Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Lilly USA Corporation Minority
Tenmile Venture Capital Minority
Alexandria Venture Investments Venture Capital Minority
Casdin Capital Venture Capital Minority
DCVC Bio Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Creyon FAQs

  • When was Creyon founded?

    Creyon was founded in 2019.

  • Where is Creyon headquartered?

    Creyon is headquartered in Durham, NC.

  • What is the size of Creyon?

    Creyon has 46 total employees.

  • What industry is Creyon in?

    Creyon’s primary industry is Drug Discovery.

  • Is Creyon a private or public company?

    Creyon is a Private company.

  • What is Creyon’s current revenue?

    The current revenue for Creyon is .

  • How much funding has Creyon raised over time?

    Creyon has raised $45.5M.

  • Who are Creyon’s investors?

    Lilly USA, Tenmile, Alexandria Venture Investments, Casdin Capital, and DCVC Bio are 5 of 7 investors who have invested in Creyon.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process